Skip to content

Author

Xiao-Yang Shi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Thermosensitive RGD-modified liposomes co-loading Fe3O4 and sorafenib for synergistic photothermal-chemotherapy of hepatocellular carcinoma.

Sorafenib (SRF) therapy for hepatocellular carcinoma (HCC) is limited by dose-limiting toxicities, inadequate tumor exposure, and the inability to confine drug action spatiotemporally, leading to suboptimal efficacy and a narrow therapeutic window. Here we report an RGD-functionalized DPPC-based thermosensitive liposom...

Si-Zhan Peng, Li-Feng Hang, Xiao-Feng Li et al. · 0 citations
Review Open access Jul 2026

Global impact of hepatitis B vaccination on the risk of hepatocellular carcinoma: a systematic review and meta-analysis

HBV vaccination is associated with a significant and durable reduction in HCC risk, independent of demographic, geographic, or vaccine-related factors, consistent with the view that universal HBV immunization is among the most effective population-level cancer prevention strategies worldwide.

Jing-Yao Wang, Jie Xu, Juan Meng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.